VOYA Investment Management
OTLK icon

VOYA Investment Management’s Outlook Therapeutics OTLK Stock Holding History

VOYA Investment Management’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,522
Closed -$12K – 2854
2023
Q4 		$12K Buy
+1,522
New +$12.9K ﹤0.01% 2897
2023
Q3 		– Sell
-3,278
Closed -$114K – 2920
2023
Q2 		$114K Buy
3,278
+241
+8% +$6.57K ﹤0.01% 2755
2023
Q1 		$66.2K Buy
3,037
+687
+29% +$15.4K ﹤0.01% 2760
2022
Q4 		$50.8K Hold
2,350
– – ﹤0.01% 2850
2022
Q3 		$57.3K Hold
2,350
– – ﹤0.01% 2880
2022
Q2 		$48K Buy
2,350
+422
+22% +$12.1K ﹤0.01% 2750
2022
Q1 		$69K Buy
1,928
+283
+17% +$8.84K ﹤0.01% 2561
2021
Q4 		$45K Sell
1,645
-156
-9% -$5.57K ﹤0.01% 2750
2021
Q3 		$78K Hold
1,801
– – ﹤0.01% 2780
2021
Q2 		$90K Buy
+1,801
New +$83.5K ﹤0.01% 2784

Other funds holding OTLK

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

VOYA Investment Management's OTLK Position: Q1 2024 in Review

VOYA Investment Management sold out of Outlook Therapeutics (OTLK) in Q1 2024, closing a stake of 1,522 shares — an estimated $12K sold.

VOYA Investment Management first reported a position in OTLK in Q2 2021 and held it in 10 quarters. The position peaked at $114K in Q2 2023. 56 funds tracked by Wall St. Rank hold OTLK as of Q1 2024.

  • VOYA Investment Management reported no remaining Outlook Therapeutics position as of Q1 2024 after selling out during the quarter.
  • VOYA Investment Management sold 1,522 Outlook Therapeutics shares in Q1 2024, an estimated $12K.
  • VOYA Investment Management first reported a position in Outlook Therapeutics in Q2 2021 and held it in 10 quarters.
  • VOYA Investment Management's Outlook Therapeutics position peaked at $114K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2024.

Based on VOYA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.